Company intelligence / Profile preview

Anbiotec

Ownership: Private
Development stage: Other

Overview

Anbiotec is an Italian biotechnology and medical device company specializing in the development and manufacture of advanced biomaterials for regenerative medicine and surgery. Founded in 1994 and headquartered in Rome, the company focuses on providing innovative solutions for bone and tissue regeneration, including bone substitutes, membranes, and skin substitutes. Their product portfolio, marketed under the Anbio brand, serves various clinical fields such as orthopedics, neurosurgery, and dentistry. Anbiotec integrates research and development with specialized manufacturing to produce high-quality biological grafts and synthetic substitutes. The company also offers diagnostic kits and surgical instrumentation to support comprehensive healthcare delivery.

Therapeutic areas: OtherRheumatologyDermatology
Modalities: BiologicDeviceProtein
Industry: Biotech

Beyond the preview

Go deeper on Anbiotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anbiotec.